Publication | Open Access

Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma

Neuro-oncologyMedicinal ChemistryGliomaReactive Nitrogen SpecieMedicineNitrosative StressMalignant Glioma-L-prolinamide DihydrochlorideAnti-cancer AgentHigh-grade GliomasPharmacologyRadiation OncologyPharmaceutical ChemistryNew PotentDrug Discovery